MYD88 and Parkinson disease: In the CNS, MPTP administration has repeatedly been used as a model for PD [56-58] and given our findings for the role of the MyD88-dependent pathway in the ENS [55], we have now sought to look at the contribution of this pathway to CNS dopaminergic cell loss using the same cohort of mice.